Status:
TERMINATED
Tanezumab In Osteoarthritis Of The Hip Or Knee
Lead Sponsor:
Pfizer
Conditions:
Osteoarthritis
Eligibility:
All Genders
18-75 years
Phase:
PHASE3
Brief Summary
The purpose of the study is to test the efficacy and safety of 2 doses of tanezumab compared to oxycodone CR and placebo in patients with osteoarthritis
Detailed Description
This study was terminated on 13 Dec 2010 following a US FDA clinical hold for tanezumab osteoarthritis clinical studies which halted dosing and enrollment of patients on 23 June 2010 for potential saf...
Eligibility Criteria
Inclusion
- osteoarthritis of the knee or hip according to Kellgren-Lawrence x-ray grade of 2
Exclusion
- pregnancy or intent to become pregnant
- BMI greater than 39
- other severe pain, significant cardiac, neurological or psychiatric disease
Key Trial Info
Start Date :
October 30 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 4 2011
Estimated Enrollment :
614 Patients enrolled
Trial Details
Trial ID
NCT00985621
Start Date
October 30 2009
End Date
February 4 2011
Last Update
May 14 2021
Active Locations (112)
Enter a location and click search to find clinical trials sorted by distance.
1
Achieve Clinical Research
Birmingham, Alabama, United States, 35209
2
Alabama Orthopaedic Clinics, PC
Mobile, Alabama, United States, 36608
3
Horizon Research Group, Inc.
Mobile, Alabama, United States, 36608
4
Arizona Research Center, Inc.
Phoenix, Arizona, United States, 85023